Fribourg, 8 June 2018
AEVIS VICTORIA SA sold its stake in BioTelemetry, thus realising a total capital gain of CHF 14.3 million on its investment in LifeWatch
AEVIS VICTORIA SA (AEVIS VICTORIA) sold yesterday its 1.6% stake in US based BioTelemetry, Inc. (BEAT), obtained as a result of their public acquisition and exchange offer on LifeWatch AG. This transaction will allow AEVIS VICTORIA to generate a financial gain of CHF 6.6 million, which will have a positive impact on the 2018 first half-year results. Combined with the realised gain of CHF 7.8 million in 2017, AEVIS VICTORIA's capital gain on its investment in LifeWatch reaches CHF 14.3 million.
For more information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, email@example.com, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, firstname.lastname@example.org, +41 (0) 26 350 02 02
AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in services to people, healthcare, hospitality, life sciences and lifestyle. AEVIS VICTORIA′s main shareholdings are Swiss Medical Network SA, the second largest group of private hospitals in Switzerland, Victoria-Jungfrau Collection AG, a luxury hotel group managing four luxury hotels in Switzerland, a hospitals and hospitality real estate division, Medgate, the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.